Immunological factors of cardiovascular risk (TNF-α) depending on various hemodynamic forms of arterial hypertension in adolescents.

Authors

  • T. A. Gayduk
  • L. R. Shostakovich-Koretska
  • O. I. Gayduk

DOI:

https://doi.org/10.26641/2307-0404.2018.1(part2).126938

Keywords:

arterial hypertension, tumor necrosis factor-α, risk factors, adolescents

Abstract

119 children aged 12-17 years with the stable and labile forms of arterial hypertension (AH) and prehypertension hospitalized to cardiopulmonary department due to ambulatory single-measured blood pressure (BP) elevation were observed. The level of TNF-α in adolescents with different forms of AH and prehypertension as well as the correlation of this marker with other cardiovascular risk factors was determined. There was a significant increase in the mean value (9.50±0.54 pg/ml) and frequency (45.6%) of increase of TNF-α level in the group of children with AH compared with the group of children with normotension (6.43±0,64 pg/ml and 12.5% respectively). There is shown a tendency to increase of TNF-α levels, depending on the degree of stabilization of AH with the highest level of proinflammatory cytokines of TNF-α in the group of children with stable systolic BP. The positive correlation of TNF-α with the daily BP monitoring indicators, especially with the level of diastolic BP and its variability at night was revealed.

Author Biographies

T. A. Gayduk

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

L. R. Shostakovich-Koretska

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

O. I. Gayduk

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

References

Gorbas' IM. [Epidemiological and medical-social aspects of arterial hypertension]. Arterіal'na gіpertenzіya u pіdlіtkіv: problemi ta perspektivi. Kharkiv. 2011;11-19. Ukrainian.

Korenev NM, Bogmat LF, Nosova EM. [Arterial hypertension in adolescents: factors of stabilization and progression]. Zdorov'e rebenka. 2014;3(54):6-11. Russian.

KorenevNM, Bogmat LF, Nikonova VV, et al. [Metabolic and hemodynamic peculiarities of arterial hypertension in adolescents, depending on body weight]. Arterial'naya gipertenziya. 2015;1(39):36-44. Ukrainian.

Metregune NG, Bikir-Tkhoryak LI, Kozhokar' SV. [The importance of adipokines and insulin re­sistance in the development of hypertension in children with overweight and obesity]. Perinatologiya i pediatriya. 2015;4(64):108-10. Russian. doi: 10.15574/PP.2015.64.108

Barbaro NR, De Araujo T, Tanus-Santos JE, et al. Vascular damage in resistant hypertension: TNF-α inhibition effects on endothelial cells. BioMed Research International. 2015;631594. doi: 10.1155/2015/631594

Ewald DR,Haldeman LA.Risk factors in ado­les­cent hypertension. Glob Ped Health. 2016;3:2333794X15625159. doi: 10.1177/2333794X15625159

Wimalasundera R, Fexby S, Regan L, et al. Effect of TNF-α and interleukin 1β on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol. 2003;138(7):1285-94. doi: 10.1038/sj.bjp.0705168

Li Y-y. TNF-α G308α gene polymorphism and essential hypertension: A meta-analysis involving 2244 participants. PLoS One. 2012;7(4):e35408. doi: 10.1371/journal.pone.0035408

Sookoian S, Garciía SI, Gianotti TF, et al. The G-308A promoter variant of the TNF-α gene is associated with hypertension in adolescents harboring the metabolic syndrome. Am J Hypertension. 2005;18(10):1271-75. doi: 10.1016/j.amjhyper.2005.04.014

Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Transl Res. 2017;183:57-70. doi: 10.1016/j.trsl.2017.01.001

How to Cite

1.
Gayduk TA, Shostakovich-Koretska LR, Gayduk OI. Immunological factors of cardiovascular risk (TNF-α) depending on various hemodynamic forms of arterial hypertension in adolescents. Med. perspekt. [Internet]. 2018May4 [cited 2024Dec.19];23(1(part2):29-33. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/126938

Issue

Section

CLINICAL MEDICINE